Cargando…

Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes

The monitoring of minimal residual disease (MRD) in Philadelphia-negative acute lymphoblastic leukemia (ALL) requires the identification at diagnosis of immunoglobulin/T-cell receptor (Ig/TCR) rearrangements as clonality markers. Aiming to simplify and possibly improve the patients’ initial screenin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavagna, Roberta, Guinea Montalvo, Marie L., Tosi, Manuela, Paris, Michela, Pavoni, Chiara, Intermesoli, Tamara, Bassan, Renato, Mosca, Andrea, Rambaldi, Alessandro, Spinelli, Orietta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352935/ https://www.ncbi.nlm.nih.gov/pubmed/32526928 http://dx.doi.org/10.3390/cancers12061505

Ejemplares similares

Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations
por: Salmoiraghi, Silvia, et al.
Publicado: (2020)

MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
por: Tosi, Manuela, et al.
Publicado: (2021)

Prognostic Significance and Treatment Implications of Minimal Residual Disease Studies in Philadelphia-Negative Adult Acute Lymphoblastic Leukemia
por: Spinelli, Orietta, et al.
Publicado: (2014)

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
por: Bassan, Renato, et al.
Publicado: (2020)

Highly aggressive T-cell acute lymphoblastic leukemia with t(8;14)(q24;q11): extensive genetic characterization and achievement of early molecular remission and long-term survival in an adult patient
por: Parolini, M, et al.
Publicado: (2014)

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia
por: Lussana, Federico, et al.
Publicado: (2019)

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
por: Salmoiraghi, Silvia, et al.
Publicado: (2020)

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response
por: Iurlo, Alessandra, et al.
Publicado: (2014)

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia
por: Bassan, R, et al.
Publicado: (2014)

Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia
por: Fries, Carol, et al.
Publicado: (2022)

P1180: BURKITT INTERNATIONAL PROGNOSTIC INDEX EVALUATED IN PATIENTS TREATED WITH R-GMALL PROTOCOL
por: Rizzuto, Giuliana, et al.
Publicado: (2023)

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia
por: Chiaretti, Sabina, et al.
Publicado: (2014)

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
por: Caprioli, Chiara, et al.
Publicado: (2020)

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
por: Rizzuto, Giuliana, et al.
Publicado: (2022)

Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population
por: Carobolante, Francesca, et al.
Publicado: (2020)

Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia
por: Shin, Saeam, et al.
Publicado: (2017)

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
por: Bassan, Renato, et al.
Publicado: (2023)

Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study
por: Boissel, Nicolas, et al.
Publicado: (2023)

Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid Leukemia
por: Pagani, Ilaria S., et al.
Publicado: (2014)

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
por: Swaminathan, Srividya, et al.
Publicado: (2015)

PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis
por: Kroeze, Leonie I., et al.
Publicado: (2022)

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?
por: Levy, Gabriel, et al.
Publicado: (2022)

Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2022)

Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper
por: Soverini, Simona, et al.
Publicado: (2020)

Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia
por: Lang, Fabian, et al.
Publicado: (2015)

Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes
por: Studd, James B., et al.
Publicado: (2021)

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913
por: Chiaretti, Sabina, et al.
Publicado: (2020)

Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?
por: Gritti, Giuseppe, et al.
Publicado: (2017)

Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia
por: de Smith, Adam J., et al.
Publicado: (2016)

Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
por: Woodward, Eleanor L., et al.
Publicado: (2023)

Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination
por: Taurino, Daniela, et al.
Publicado: (2021)

Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
por: van Bladel, Diede A. G., et al.
Publicado: (2021)

Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
por: Brüggemann, Monika, et al.
Publicado: (2019)

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia
por: Sampathi, Shilpa, et al.
Publicado: (2022)

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?
por: Lussana, Federico, et al.
Publicado: (2020)

Clustering-based identification of clonally-related immunoglobulin gene sequence sets
por: Chen, Zhiliang, et al.
Publicado: (2010)

Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
por: Maino, Elena, et al.
Publicado: (2015)

A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia
por: Bassan, Renato, et al.
Publicado: (2019)

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS
por: Scheijen, Blanca, et al.
Publicado: (2019)

Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
por: van Bladel, Diede A. G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ro0ju0oaaa3n643fgdhrjuqmpt